APA (7th ed.) Citation

ML, M., RO, Y., DP, M., M, G., AG, S., & D, L. (2024). Use of Sodium-Glucose Cotransporter-2 Inhibitors in Adults Aged ≥65 Years With Type 2 Diabetes and Cardiovascular Disease: A Cross-sectional Study of Different Drug Funding Policies. Canadian journal of diabetes, 48(8), 524. https://doi.org/10.1016/j.jcjd.2024.09.003

Chicago Style (17th ed.) Citation

ML, McCreary, Yeung RO, Manca DP, Greiver M, Singer AG, and Lau D. "Use of Sodium-Glucose Cotransporter-2 Inhibitors in Adults Aged ≥65 Years With Type 2 Diabetes and Cardiovascular Disease: A Cross-sectional Study of Different Drug Funding Policies." Canadian Journal of Diabetes 48, no. 8 (2024): 524. https://doi.org/10.1016/j.jcjd.2024.09.003.

MLA (9th ed.) Citation

ML, McCreary, et al. "Use of Sodium-Glucose Cotransporter-2 Inhibitors in Adults Aged ≥65 Years With Type 2 Diabetes and Cardiovascular Disease: A Cross-sectional Study of Different Drug Funding Policies." Canadian Journal of Diabetes, vol. 48, no. 8, 2024, p. 524, https://doi.org/10.1016/j.jcjd.2024.09.003.